SARS-CoV-2 infection is mild in the majority of individuals but progresses into severe
pneumonia in a small proportion of patients. The increased susceptibility to severe disease in the …

Immune dysregulation is an important component of the pathophysiology of COVID-19. A
large body of literature has reported the effect of immune-based therapies in patients with …

Background Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal
disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in …

Control of nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA)
has been unsuccessful in most countries. Yet, some countries have maintained low endemic …

Objective To review and appraise the validity and usefulness of published and preprint reports
of prediction models for prognosis of patients with covid-19, and for detecting people in …

Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …

Background Estimating attributable mortality of ventilator-associated pneumonia has been
hampered by confounding factors, small sample sizes, and the difficulty of doing relevant …

Importance Infection is frequent among patients in the intensive care unit (ICU). Contemporary
information about the types of infections, causative pathogens, and outcomes can aid the …

Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Background In countries with declining numbers of confirmed cases of COVID-19, lockdown
measures are gradually being lifted. However, even if most physical distancing measures …